C82.62 Cutaneous follicle center lymphoma, intrathoracic lymph nodes

Name of the Condition

• Cutaneous Follicle Center Lymphoma, Intrathoracic Lymph Nodes

Summary

Cutaneous follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the skin, specifically affecting B-cells. It is characterized by the slow growth of cancerous lymphocytes, which can form nodules or plaques in the skin. When involving intrathoracic lymph nodes, it may present with localized or regional lymphadenopathy in addition to cutaneous lesions. This condition is typically indolent but may progress over time.

Causes

The exact cause of cutaneous follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development.

Risk Factors

• Age: More common in individuals over 60.
• Family history: A history of lymphoma can increase risk.
• Immune system deficiencies.
• Certain infections, such as hepatitis C.

Symptoms

• Painless skin nodules or plaques.
• Red or purple lesions.
• Lesions that may be localized or widespread.
• Pruritus (itching) in some cases.
• Swelling of lymph nodes in the intrathoracic region (e.g., chest, mediastinum).

Diagnosis

Diagnosis involves a physical examination, medical history review, skin biopsy to confirm the presence of lymphoma, and possibly imaging studies (e.g., CT or MRI) to assess for intrathoracic lymph node involvement. Additional tests, such as lymph node biopsy or blood work, may be performed to evaluate systemic spread.

Treatment Options

• Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild.
• Topical therapies: Creams or ointments applied to the skin.
• Radiation therapy: Targeted treatment for localized lesions or lymph nodes.
• Systemic therapies: Chemotherapy or immunotherapy for widespread or progressive disease.
• Surgical excision: Removal of isolated lesions or affected lymph nodes.

Prognosis and Follow-Up

Prognosis is generally favorable due to the indolent nature of the disease, but it may vary based on extent of involvement and response to treatment. Regular follow-up with imaging and clinical assessments is recommended to monitor for progression or recurrence.

Complications

• Localized or systemic progression of lymphoma.
• Infection due to immune system involvement.
• Treatment-related side effects (e.g., from radiation or chemotherapy).

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known environmental triggers (if identifiable).
• Practice good skin care to reduce irritation.

When to Seek Professional Help

Seek medical attention if you notice new or worsening skin lesions, persistent lymph node swelling, unexplained weight loss, fever, or night sweats.

Tips for Medical Coders

Use code C82.62 for cutaneous follicle center lymphoma with intrathoracic lymph node involvement. Ensure documentation specifies the anatomical location (intrathoracic) and confirms the diagnosis via biopsy or imaging. Code only when the condition is explicitly documented; do not infer involvement without clinical evidence.